Summary
Glassbeam has 2 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.
Reviewer brief
As of 17 Sep 2026, Glassbeam is listed in the FedRAMP registry as FedRAMP Authorized, with an authorization issued 23 May 2025 and no expiration date recorded. As of 17 Sep 2026, Glassbeam is listed in the EU-US Data Privacy Framework registry as active, covering EU-US, UK Extension, and Swiss-US Certifications, issued 30 Apr 2024 and set to expire 15 Apr 2027. As of 17 Sep 2026, no public evidence found for SOC 2 status for Glassbeam. As of 17 Sep 2026, no public evidence found for HIPAA or a BAA offering for Glassbeam. As of 17 Sep 2026, no subprocessor entries were found in the evidence provided for Glassbeam.
- FedRAMP: listed in FedRAMP registry as FedRAMP Authorized, issued 23 May 2025, no expiration date, as of 17 Sep 2026.
- EU-US Data Privacy Framework: listed in DPF registry as active (EU-US, UK Extension, SW-US Certifications), issued 30 Apr 2024, expires 15 Apr 2027, as of 17 Sep 2026.
- SOC 2 and HIPAA: no public evidence found for either framework as of 17 Sep 2026.
Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.
Among analytics vendors
2verified rows
Category median 0, across 85 indexed analytics vendors. Glassbeam has more verified rows than 100 percent of them.
data extractionhealthcare analyticsmachine dataoperations intelligence
Compare with similar vendors
Pick your own comparisonCompliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the Analytics category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.
